PT  - JOURNAL ARTICLE
AU  - Ketcheson, David I.
TI  - Optimal control of an SIR epidemic through finite-time non-pharmaceutical intervention
AID  - 10.1101/2020.05.05.20091439
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.05.05.20091439
4099  - http://medrxiv.org/content/early/2020/05/09/2020.05.05.20091439.short
4100  - http://medrxiv.org/content/early/2020/05/09/2020.05.05.20091439.full
AB  - We consider the problem of controlling an SIR-model epidemic by temporarily reducing the rate of contact within a population. The control takes the form of a multiplicative reduction in the contact rate of infectious individuals. The control is allowed to be applied only over a finite time interval, while the objective is to minimize the total number of individuals infected in the long-time limit, subject to some cost function for the control. We first consider the no-cost scenario and analytically determine the optimal control and solution. We then study solutions when a cost of intervention is included, as well as a cost associated with overwhelming the available medical resources. Examples are studied through the numerical solution of the associated Hamilton-Jacobi-Bellman equation. Finally, we provide some examples related directly to the current pandemic.AMS subject classification. 92D30, 34H05, 49N90, 92-10, 49L12Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe author was supported by funding from King Abdullah University of Science & Technology (KAUST).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNo data is associated with this article. Some related code is available at https://github.com/ketch/SIR_control